Objective. Prolonged treatment with neuroleptics has been shown to induce FosB/ΔFosB expression in several brain regions including the medial prefrontal cortex, dorsomedial and dorsolateral striatum, ventrolateral and dorsolateral septum, nucleus accumbens shell and core, and the hypothalamic paraventricular nucleus (PVN). Some of these regions are known to be also stress responsive. This study was designed to determine whether repeated clozapine (CLZ) administration for 7 consecutive days to Wistar rats may modify FosB/ΔFosB expression in the above-mentioned brain areas induced by acute stress or novel stressor that followed 13-day chronic mild stress preconditioning.
thalamic paraventricular nucleus (PVN), and the hippocampus (Melia et al. 1994; Senba et al. 1994; Senba and Ueyama 1997; Bubser and Deutch 1999; Morrow et al. 2000) . In contrary, repeated exposure to stress desensitizes c-Fos response in many of these brain regions (Melia et al. 1994; Umemoto et al. 1997; Stamp and Herbert 1999) and in some of them increases FosB-like immunoreactivity Herbert 1999, 2001) . Perrotti et al. (2004) have proven that protein responsible for this FosB-like immunoreactivity after chronic stress is in fact ΔFosB, actually 35-37 kD isoform of FosB/ΔFosB. Induction of FosB/ΔFosB by chronic stress is evident in numerous brain regions but most pronounced in the frontal cortex, nAcc, basolateral nucleus of the amygdala, lateral septum, and locus coeruleus (Perrotti et al. 2004) .
Acute and chronic antipsychotics treatments induce c-Fos and FosB/ΔFosB expressions in different brain regions, too (Sebens et al. 1995) . Chronic drug exposure desensitizes c-Fos response (Sebens et al. 1995; Hiroi and Graybiel 1996; Atkins et al. 1999 ). However, for both typical and atypical neuroleptics it may take days/weeks to achieve the maximal efficacy (Kontkanen et al. 2002) . ΔFosB, unlike c-Fos and full-length FosB/ΔFosB, accumulates along with the chronic drug exposure because of its long half-life degradation (Chen et al. 1997) . Dietz et al. (2014) have detected increased ΔFosB levels in the prefrontal cortex (PFC) of medicated schizophrenic patients, but not in the non-medicated ones. The above-mentioned authors have confirmed that augmented ΔFosB levels are the results of the prolonged drug action. ΔFosB is thought to mediate some of the longer-lasting transcriptional changes induced by antipsychotic drugs in the nAcc and dorsal striatum (Nestler et al. 2001; McClung and Nestler 2003) . Increased ΔFosB expression has been found in the caudate putamen after treatment with a typical (haloperidol) and also atypical (risperidone, olanzapine, and asenapine) neuroleptics, in the nAcc after asenapine and haloperidol treatment, and in the PFC only after haloperidol application (Atkins et al. 1999; Majercikova et al. 2016 ). CLZ did not stimulate ΔFosB expression in any of the areas studied (Atkins et al. 1999 ). Hiroi and Graybiel (1996) have obtained similar data in the caudate putamen. After 8-day treatment with typical neuroleptics, the above-mentioned authors have observed augmented levels of ΔFosB, however, atypical CLZ did not increase but even downregulated the inducibility of ΔFosB in the striatum. On the other hand, Grande et al. (2004) have shown that neuroleptics may differentially induce ΔFosB in the nAcc and the caudate putamen. While in the nAcc they detected increased ΔFosB after chronic haloperidol and CLZ application, in the caudate putamen, ΔFosB expression was elevated only after haloperidol treatment.
Former studies have indicated that the effect of antipsychotics in the clinical use is partly interlinked with the status of the stress responsive hypothalamopituitary-adrenal (HPA) axis (Sebens et al. 2001) . Moreover, in our previous study we have shown that CLZ can modify c-Fos response to stress in some of the brain structures (Osacka et al. 2018) . The aim of our current study was to determine whether 7-day CLZ administration may modify FosB/ΔFosB expression in the selected forebrain areas (which are known to be affected by antipsychotics and also by stress) in acutely stressed animals and animals previously exposed to 13-day chronic mild stress and then to a novel stressor. We were interested to find out: 1) the effect of 7-day CLZ administration on FosB/ ΔFosB expression in the selected forebrain areas in unstressed animals; 2) whether 7-day CLZ administration may modify FosB/ΔFosB expression in the selected forebrain areas in animals exposed to the acute stimulus -forced swimming (FSW); and 3) whether 7-day CLZ administration may modify FosB/ ΔFosB expression in the selected forebrain areas in animals 13-day preconditioned with mild unpredictable stress (CMS) and then exposed to novel stressor -FSW. The activity of cells was evaluated by FosB/ ΔFosB immunoreactivity (that reflects chronic stimulation) in the medial prefrontal cortex (mPFC), the dorsolateral (DL Str) and the dorsomedial (DM Str) striatum, the dorsolateral (dLS) and the ventrolateral (vLS) septum, the accumbens nucleus core (nAcc Core) and shell (nAcc Shell), and the PVN.
Material and methods
Animals. Forty male Wistar rats (age 7-8 weeks, weighing 200-230 g at the beginning of the experiment) were purchased from Charles River (Germany). Animals were housed one per cage in a room with controlled temperature (22±1 °C), light (12-h light/ dark cycle with lights on at 06:00 h), and humidity (55%±10). Animals were provided with a regular rat chow (dry pellets) and tap water ad libitum. Principles of the laboratory animal care and the experimental procedures used have been approved by Animal Care Committee of the Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Slovak Republic.
Experimental design. Experimental animals were randomly divided into the following groups: 1) unstressed animals treated with vehicle for 7 days (VEH, n=4); 2) unstressed animals treated with CLZ for 7 days (CLZ, n=4); 3) 7 days VEH-treated animals and on the last day exposed to acute stressor -forced swimming (VEH+FSW, n=8); 4) 7 days CLZ-treated animals on the last day exposed to acute stressor -forced swimming (CLZ+FSW, n=8); 5) animals 13 days preconditioned with stress, since the 8 th day treated with VEH and on the 14 th day exposed to novel stressor -forced swimming (CMS+VEH, n=8); 6) animals 13 days preconditioned with stress, since the 8 th day treated with CLZ and on the 14 th day exposed to novel stressor -forced swimming (CMS+CLZ, n=8). The animals were intraperitoneally (i.p.) injected with vehicle (0.1% acetic acid in saline (100 µl/100 g, Slavus, Slovakia) or CLZ (10 mg/kg/day; SigmaAldrich, USA) dissolved in vehicle (Kim et al. 2012) for consecutive 7 days. Stress preconditioned animals were exposed to CMS for 13 days. The stressors included: restraint stress in plastic restrainers (30-60 min), cages switch overnight, crowding overnight, cold room (4 °C; 40-60 min), and open field (OF, 5 min). The animals received one stress challenge per day. In order to minimize the stressors predictability, the particular stressor was applied each day at different time. On the last day of the experiment, FSW was used as an acute stressor in VEH+FSW/CLZ+FSW experimental groups or as a novelty stressor in CMS+VEH/CMS+CLZ experimental groups. The FSW was performed in a tank (plexiglas cylinder with a height of 45 cm and diameter of 20 cm) filled with approximately up to 31 cm of water height (23-25 °C) for 10 min.
Ninety minutes after the FSW and 120 min after the last CLZ injection, the animals were anesthetized with sodium pentobarbital (50 mg/kg of b.w., i.p.; Spofa, Czech Republic), perfused with 50 ml of cold isotonic saline (Braun, Germany) containing 450 μl of heparin (5000 IU/l, Zentiva, Prague, Czech Republic), followed by 250 ml of fixative containing 4% paraformaldehyde (Sigma-Aldrich, USA) in 0.1 M phosphate buffer (PB, pH 7.4). After the fixation, the brains were removed and postfixed in a fresh fixative overnight. Then, the brains were two times washed in 0.1 M PB, infiltrated with 30% sucrose for 2 days at 4 °C, and cut with the cryocut (HYRAX C-50, Carl Zeiss, Germany) into 30 μm thick coronal sections into 4 series.
Immunohistochemistry. Sections with the studied brain areas from the 1 st and 3 rd series were used for the following immunohistochemical reaction. Free floating sections were repeatedly washed in cold 0.1 M PB and preincubated with 0.3% H 2 O 2 (Sigma-Aldrich, USA) in 0.1 M PB for 30 min at room temperature (RT). Then the sections were rinsed 3×10 min in 0.1 M PB and incubated with a mouse monoclonal anti-FosB/ΔFosB antibody (1:500, ab11959, Abcam, Cambridge, UK) diluted in 0.1 M PB containing 4 % normal goat serum (Gibco, Grand Island, NY, USA), 0.5% Triton X-100 (Sigma-Aldrich, USA), and 0.1% sodium azide (Sigma-Aldrich, USA) for 48 h at 4 °C. After several rinsing in 0.1 M PB, the sections were incubated with biotinylated goat anti-rabbit IgG (1:500, Vector Laboratories, Inc., Burlingame, CA, USA) in 0.1 M PB for 90 min at RT. Next 0.1 M PB rinsing was followed by incubation with the avidin-biotin peroxidase complex (1:250, Vector Laboratories, Inc., Burlingame, CA, USA) for 90 min at RT. After several washings in 0.05 M sodium acetate buffer (SAB, pH 6.0), FosB/ΔFosB antigenic sites were visualized by nickel-enhanced 3,3'-diaminobenzidine tetrahydrochloride (2.5% nickel chloride, 0.0625% DAB, Sigma-Aldrich, USA), in SAB containing 0.0006% hydrogen peroxide until black staining of the FosB/ΔFosB labeled nuclei was achieved. The developing process was monitored under the light microscope and the developing time ranged from 5 to 10 min. Immunostaining reactions were conducted by an unbiased manner.
Quantification of FosB/ΔFosB immunoreactive cells. Quantification of FosB/ΔFosB immunoreactive cells was performed in the brain structures at the following Bregma levels: the mPFC (3.2-2.7 mm), nAcc Shell, nAcc Core (1.6-1 mm), vLS, dLS, DL Str, and DM Str (1.2-0.7 mm), and PVN (-1.08 to -1.8 mm) (Paxinos and Watson 1998) (Figure 1 ). Digital images of the selected areas were captured at 100× magni- 1.0 mm from Bregma; (C) -1.8 mm from Bregma; 1 -medial prefrontal cortex; 2 -nucleus accumbens core; 3 -nucleus accumbens shell; 4 -ventrolateral septum; 5 -dorsolateral septum; 6 -dorsomedial striatum; 7 -dorsolateral striatum; 8 -hypothalamic paraventricular nucleus. fication with Axio Scope.A1, and AxioCam ERc 5s camera (Carl Zeiss, Germany). FosB/ΔFosB positive neurons were counted manually in CellCounter1.2. (at least 4 sections/structure/animal). Counting of FosB/ΔFosB immunopositive cells was performed by a person blind to treatment and conditions. Number of FosB/ΔFosB immunopositive cells is expressed unilaterally.
Statistical analysis. FosB/ΔFosB analysis was performed by two-way ANOVA for factors treatment (VEH and CLZ) and conditions (stress exposure) followed by Tukey post hoc test. The results are reported as mean ± S.E.M. Differences were considered significant at p<0.05. The outliers were excluded if the data point more than 1.5 interquartile ranged below the first quartile or above the third quartile.
Results
In the mPFC, two-way ANOVA revealed influence of the stress on FosB/ΔFosB expression (F(2,35)=10.565, p<0.001). In the VEH-treated animals, exposure to FSW, as an acute stressor and also as a novel stressor, increased the number of FosB/ΔFosB immunopositive cells in comparison with the unstressed animals (p=0.002, resp. p=0.005; Figure 2 ).
In the DL Str, two-way ANOVA confirmed the effect of the stress exposure (F(2,37)=10.483, p<0.001) on FosB/ΔFosB immunoreactivity. VEH-injected animals that underwent a single FSW and FSW with previous CMS exhibited more FosB/ΔFosB immunoreactive cells than the VEH unstressed ones (p=0.001, resp. p=0.004; Figure 3A) . Also, CMS+CLZ animals exhibited more FosB/ΔFosB-immunoreactive profiles in comparison with the CLZ unstressed ones (p=0.044; Figure 3A ).
In the DM Str, the effect of the treatment (F(2,33)=17.199, p<0.001) and interaction of the treatment and stress exposure (F(2,33)=3.691, p=0.038) on FosB/ΔFosB immunoreactivity was found by two-way ANOVA. VEH+FSW and CMS+VEH experimental groups showed markedly stronger FosB/ ΔFosB expression than the unstressed VEH-injected one (p<0.001, resp. p=0.008; Figure 3B ). The animals that underwent single FSW (VEH+FSW) had significantly more FosB/ΔFosB immunopositive cells than the stress preconditioned ones (CMS+VEH, p=0.044; Figure 2 . Graph demonstrating the effect of the stress exposure and CLZ treatment on FosB/ΔFosB expression in the mPFC. VEHtreated animals exposed to FSW and also those exposed to previous CMS had more FosB/ΔFosB immunoreactive cells than the unstressed ones ( ** p<0.01). Data are expressed as mean ± SEM. Photomicrographs illustrate the stimulatory effect of acute FSW and CMS followed by novelty on FosB/ΔFosB expression in the mPFC. Abbreviations: CMS+CLZ -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with CLZ; CMS+VEH -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with VEH; CLZ -clozapine; CLZ+FSW -animals exposed to acute stressor -forced swimming, treated with CLZ; fmi -forceps minor corpus callosum; mPFC -medial prefrontal cortex; VEH -vehiculum; VEH+FSW -animals exposed to acute stressor -forced swimming, treated with VEH. Figure 3B ). In the CLZ-treated animals, FosB/ΔFosB expression was elevated in the rats exposed to a single FSW and also in those exposed to a previous CMS when compared with the unstressed CLZ-injected ones (p=0.045, resp. p=0.018; Figure 3B ). Notably, in the single FSW exposed rats, CLZ markedly suppressed FosB/ΔFosB immunoreactivity (p=0.006; Figure 3B ).
In the vLS, the effect of the treatment (F(1,35)=19.974, p<0.001), stress exposure (F(2,35)=3.655, p=0.038), and their interaction (F(2,35)=6.898, p=0.003) on FosB/ΔFosB expression was found by two-way ANOVA. In the unstressed animals CLZ markedly stimulated FosB/ΔFosB immunoreactivity (p<0.001, Figure 4A ). VEH-injected animals that underwent single FSW and FSW with previous CMS exhibited more ΔFosB immunoreactive cells than the VEH unstressed ones (p<0.001, p=0.002; Figure 4A ).
In the dLS, two-way ANOVA confirmed the effect of the stress exposure (F(2,35)=4.535, p=0.019) on FosB/ΔFosB immunoreactivity. In the VEHtreated animals, exposure to a single FSW induced stronger FosB/ΔFosB expression in comparison with unstressed VEH-treated rats (p=0.01; Figure 4B ).
In the nAcc Core, two-way ANOVA found impact of the stress exposure (F(2,32)=5.781, p=0.008) on the number of FosB/ΔFosB immunopositive cells. In the CMS+CLZ group, more FosB/ΔFosB immunoreactive cells appeared than in the CMS+VEH (p=0.022) and CLZ+FSW (p=0.009) experimental groups ( Figure 5A ).
In the nAcc Shell, two-way ANOVA detected effect of the interaction of the treatment and stress exposure (F(2,33)=3.623, p=0.04) on FosB/ΔFosB immunoreactivity. CMS+CLZ animals expressed significantly more FosB/ΔFosB immunopositive cells than the CMS+VEH (p=0.019) and CLZ+FSW (p=0.023) ones ( Figure. 5B ).
In the PVN, effect of the treatment (F(1,34)=26.987, p<0.001) and interaction of the treatment and stress p<0.001). Data are expressed as mean ± SEM. Photomicrographs illustrate the effect of 7-day CLZ administration and FSW exposure as acute or novel stressor on FosB/ΔFosB expression in the DL Str and DM Str. Abbreviations: cc -corpus callosum; CMS+CLZ -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with CLZ; CMS+VEH -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with VEH; CLZ -clozapine, CLZ+FSW -animals exposed to acute stressor -forced swimming, treated with CLZ; DL Str -dorsolateral striatum; DM Str -dorsomedial striatum; LV -lateral ventricle; VEH -vehiculum; VEH+FSW -animals exposed to acute stressor -forced swimming, treated with VEH. p<0.001). Data are expressed as mean ± SEM. Photomicrographs illustrate the effect of 7-day CLZ administration, FSW, and CMS exposure on FosB/ΔFosB expression in the dLS and vLS. Abbreviations: cc -corpus callosum; CMS+CLZ -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with VEH; CMS+VEH -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with VEH; CLZ -clozapine; CLZ+FSW -animals exposed to acute stressor -forced swimming, treated with CLZ; dLS -dorsolateral septum; LV -lateral ventricle; vLS -ventrolateral septum; VEH -vehiculum; VEH+FSW -animals exposed to acute stressor -forced swimming, treated with VEH. exposure (F(2,34)=5.572, p=0.009) on FosB/ΔFosB expression were detected by two-way ANOVA. CMS+VEH experimental group had more FosB/ ΔFosB immunoreactive cells than the unstressed VEH group (p=0.004; Figure 6 ). In the unstressed animals and those exposed to single FSW, CLZ markedly stimulated FosB/ΔFosB expression in comparison with the VEH-treated groups (VEH vs. CLZ p<0.001; VEH+FSW vs. CLZ+FSW p=0.005; Figure 6 ).
Discussion
The present study suggests that 7-day CLZ administration increases FosB/ΔFosB expression in the selected forebrain areas in unstressed animals (PVN, vLS) and may interact either with acute or chronic stress and consequently affect the FosB/ΔFosB expression.
Our previous study, concerning c-Fos expression (as a marker of an acute stimulation), have shown that CLZ may modify c-Fos immunoreactivity in the unstressed, acutely, and repeatedly stressed animals in some of the forebrain areas (Osacka et al. 2018 ). When we compared the data from our previous study, i.e. number of cells expressing c-Fos, and the data obtained in this study, i.e. number of cells expressing FosB/ΔFosB within the same areas, we found that the cells in the dorsal striatum and nAcc of unstressed, acutely, and chronically stressed rats expressed approximately 10 times more FosB/ΔFosB immunoreactive profiles than c-Fos. In these structures, 7-day CLZ treatment and acute/chronic stress seem to affect FosB/ΔFosB expression (a marker of prolonged stimulus) more intensively than in the other areas studied.
Robust FosB/ΔFosB expression, especially after treatment with typical antipsychotics like haloperidol, has been observed in the caudate putamen and the nucleus accumbens, and a small increase also in the prefrontal cortex (Atkins et al. 1999) . Pattern of FosB/ΔFosB induction seems to be associated with Figure 5 . Graphs demonstrating the effect of the stress exposure and CLZ treatment on FosB/ΔFosB expression in the nAcc Core (A) and nAcc Shell (B). In the nAcc Core and Shell of the CMS exposed rats, CLZ significantly increased number of FosB/ΔFosB immunoposive cells compared with the VEH-treated ones and CMS+CLZ experimental group had more FosB/ΔFosB immunoreactive cells than the CLZ+FSW one ( * p<0.05, ** p<0.01, *** p<0.001). Data are expressed as mean ± SEM. Photomicrographs illustrate the effect of 7-day CLZ administration, FSW, and CMS exposure on FosB/ΔFosB expression in the nAcc Core and nAcc Shell. Abbreviations: ac -anterior commissure; CMS+CLZ -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with CLZ; CMS+VEH -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with VEH; CLZ -clozapine; CLZ+FSW -animals exposed to acute stressor -forced swimming, treated with CLZ; LV -lateral ventricle; nAcc core -nucleus accumbens core; nAcc shell -nucleus accumbens shell; VEH -vehiculum, VEH+FSW -animals exposed to acute stressor -forced swimming, treated with VEH. the extrapyramidal side effects generated by typical antipsychotics (Atkins et al. 1999) . Majercikova et al. (2016) have found elevated FosB/ΔFosB in the striatum and the nucleus accumbens also after treatment with an atypical drug, asenapine. In the most of the studies, CLZ failed to increase FosB/ΔFosB in all of the above-mentioned areas (Hiroi and Graybiel 1996; Atkins et al. 1999 ). However, Vahid-Ansari et al. (1996) and Robertson et al. (2004) have detected elevated FosB/ΔFosB immunoreactivity after CLZ application in the caudate putamen, nAcc, PFC, lateral septal nucleus, and the island of Calleja. In the present study, we found elevated FosB/ΔFosB immunoreactivity in the vLS and the PVN.
Acute and chronic stressors increased FosB/ΔFosB expression in the most of the areas studied (mPFC, PVN, striatum, septum). One of the previous studies has shown a robust ΔFosB mRNA upregulation in the striatum after acute treatment with amphetamine and very similar pattern of ΔFosB mRNA induction after restraint stress. This induction was partially reduced by repeated amphetamine/stress exposures (Alibhai et al. 2007 ). We also detected decreased FosB/ΔFosB immunoreactivity in the DM Str of chronically stressed animals exposed to a novel FSW episode when compared with the acutely stressed ones. Notably, in the PVN of chronically stressed animals exposed to a novel stressor, we found a marked FosB/ΔFosB immunoreactivity elevation (especially in its parvocellular part), but this elevation was not present after an acute FSW. These data are in contrast with the finding of Perrotti et al. (2004) , who have detected a robust induction of FosB after acute stress, but no accumulation of FosB/ΔFosB after the chronic stress. On the other hand, Kiss and Majercikova (2017) have also found increased number of FosB/ΔFosB profiles in the medial parvocellular subdivision of the PVN in chronically stressed rats.
Our previous study has demonstrated that the reactivity of the structures involved in the stress regulation can be influenced by CLZ treatment (Osacka et al. 2018) . CLZ suppressed c-Fos expression (marker of acute stimulation) in the vLS, DM Str, and nAcc after exposure to acute FSW and in the PVN after a novel stressor (Osacka et al. 2018) . Present data showed that FosB/ΔFosB expression induced by acute FSW was suppressed by CLZ in the DM Str and a similar tendency was observed also in the DL Str (but the effect did not reach statistical significance). In the striatum (especially DM Str), acute stress (FSW) seems to potentiate the effect of CLZ (as number of FosB/ΔFosB immunopositive cells was higher than in the unstressed CLZ-treated animals); however, CMS did not further stimulate it. In the PVN, CLZ seems to have highly stimulatory effect what we observed in the unstressed and acutely stressed animals, where CLZ-treated animals expressed significantly more FosB/ΔFosB immunopositive cells than the VEH-treated ones ( Figure  5 ). However, CLZ seems to be able to stimulate only certain number of cells that cannot be further potentiated by acute or chronic stress. After a novel stress, we observed the effect of CLZ in the nAcc subregions only, where CLZ markedly increased FosB/ ΔFosB immunoreactivity. It seems that the novel stress after CMS encourages the CLZ effect on FosB/ ΔFosB expression (it was markedly higher than in the acutely stressed animals).
ΔFosB is a transcription factor, which exerts its effect by enhancing or repressing the expression of other genes. In the nAcc, ΔFosB overexpression has been shown to induce GluR2 (AMPA glutamate receptor subunit) (Kelz et al. 1999 ) and suppress dynorphin expression (Zachariou et al. 2006) ; in the nAcc in drug abuse models, ΔFosB affects also Camk2a expression ). In the PFC, increased ΔFosB expression has been shown to be associated with social defeat-induced anxiety and depression like behavior and it has also been proven p<0.01). Data are expressed as mean ± SEM. Photomicrographs illustrate the effect of 7-day CLZ administration, FSW, and CMS exposure on FosB/ΔFosB expression in the PVN. Abbreviations: 3rd V -3rd ventricle; CMS+VEH -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with vehiculum; CMS+CLZ -stress preconditioned animals exposed to a novelty stressor -forced swimming, treated with clozapine; CLZ -clozapine; CLZ+FSW -animals exposed to acute stressor -forced swimming, treated with CLZ; PVN -hypothalamic paraventricular nucleus; VEH -vehiculum; VEH+FSW -animals exposed to acute stressor -forced swimming, treated with VEH.
to enhance stress susceptibility through induction of cholecystokinin-B receptor . ΔFosB targets numerous genes and further experiments are necessary to find out, which genes and consequent pathways may be affected by ΔFosB clozapine and stress inductions. However, this study showed that CLZ and stress can affect one another and modify FosB/ΔFosB immunoreactivity in some of the forebrain areas. And the dorsal striatum and nAcc seem to be areas where 7-day CLZ application and stress exposure exert their most pronounced effects.
